Epiretinal Membrane Medication

Updated: Aug 28, 2018
  • Author: Kean Theng Oh, MD; Chief Editor: Douglas R Lazzaro, MD, FAAO, FACS  more...
  • Print
Medication

Medication Summary

The goals of pharmacotherapy are to reduce morbidity and prevent complications.

Next:

Vitreolytics

Class Summary

Vitreolytic agents are used in the treatment of symptoms resulting from epiretinal membrane.

Ocriplasmin (Jetrea)

Ocriplasmin exerts proteolytic effects on the components of vitreomacular adhesion, including fibrinogen, fibronectin, and, to a lesser extent, laminin and collagen.

Previous